Contact
Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients
TO:
Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients
TO: